deltatrials
Completed OBSERVATIONAL NCT04563247

Seroprevalence of SARS-CoV-2 in Asymptomatic Frontline COVID-19 HCWs

Seroprevalence of SARS-CoV 2 Among Asymptomatic Frontline Healthcare Workers During COVID 19: A Cross Sectional Study

Sponsor: Lahore General Hospital

Conditions Covid19
Interventions IgG SARS CoV 2 antibodies
Updated 6 times since 2020 Last updated: Feb 12, 2022 Started: Jul 1, 2020 Primary completion: Feb 8, 2021 Completion: Feb 8, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Covid19, this trial is completed. The trial is conducted by Lahore General Hospital and has accumulated 6 data snapshots since 2020. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshot~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshot~Mar 2021 – ~Mar 2022 · 12 months · monthly snapshotCompleted~Mar 2022 – ~Jul 2024 · 28 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 23 months · monthly snapshotCompleted

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Mar 2022 — Jul 2024 [monthly]

    Completed

  4. Mar 2021 — Mar 2022 [monthly]

    Completed

    Status: Active Not Recruiting → Completed

  5. Jan 2021 — Mar 2021 [monthly]

    Active Not Recruiting

▶ Show 1 earlier version

  1. Oct 2020 — Jan 2021 [monthly]

    Active Not Recruiting

    First recorded

Jul 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Lahore General Hospital
Data source: Lahore General Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations